Eventide Asset Management’s Encompass Health EHC Stock Holding History

Eventide Asset Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.81M	Buy	70,302 +1,334	+2%	+$137K	0.11%	152
2025 Q4	$7.33M	Buy	+68,968	New	+$7.99M	0.11%	159
2024 Q1	–	Sell	-151,644	Closed	-$10.1M	–	165
2023 Q4	$10.1M	Sell	151,644 -18,464	-11%	-$1.2M	0.17%	120
2023 Q3	$11.4M	Sell	170,108 -19,871	-10%	-$1.37M	0.21%	116
2023 Q2	$12.9M	Hold	189,979	–	–	0.22%	113
2023 Q1	$10.3M	Sell	189,979 -4,516	-2%	-$263K	0.19%	115
2022 Q4	$11.6M	Hold	194,495	–	–	0.23%	101
2022 Q3	$8.8M	Buy	+194,495	New	+$9.73M	0.17%	107

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Eventide Asset Management's EHC Position: Q1 2026 in Review

Eventide Asset Management increased its Encompass Health (EHC) stake by 1.9% in Q1 2026, buying an estimated $137K and bringing the position to 70,302 shares worth $6.81M. The position accounts for 0.11% of the portfolio, ranked #152.

Eventide Asset Management first reported a position in EHC in Q3 2022 and has held it in 8 quarters since. The position peaked at $12.9M in Q2 2023. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Eventide Asset Management held 70,302 shares of Encompass Health worth $6.81M as of Q1 2026.
Eventide Asset Management bought 1,334 Encompass Health shares in Q1 2026, an estimated $137K.
Encompass Health made up 0.11% of Eventide Asset Management's portfolio in Q1 2026, its #152 holding.
Eventide Asset Management first reported a position in Encompass Health in Q3 2022 and has held it in 8 quarters since.
Eventide Asset Management's Encompass Health position peaked at $12.9M in Q2 2023.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.